Alcohol: Caution is advised when consuming alcohol with Cobaneuron PG 7.5mg/0.75mg/750mcg/75mg/1.5mg Soft Gelatin Capsule. Please consult your doctor. Pregnancy: Cobaneuron PG 7.5mg/0.75mg/750mcg/75mg/1.5mg Soft Gelatin Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor. Breastfeeding: Cobaneuron PG 7.5mg/0.75mg/750mcg/75mg/1.5mg Soft Gelatin Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Driving: Cobaneuron PG 7.5mg/0.75mg/750mcg/75mg/1.5mg Soft Gelatin Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur. Kidney: Cobaneuron PG 7.5mg/0.75mg/750mcg/75mg/1.5mg Soft Gelatin Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Cobaneuron PG 7.5mg/0.75mg/750mcg/75mg/1.5mg Soft Gelatin Capsule may not be needed in these patients. Please consult your doctor. Liver: Cobaneuron PG 7.5mg/0.75mg/750mcg/75mg/1.5mg Soft Gelatin Capsule should be used with caution in patients with severe liver disease. Dose adjustment of Cobaneuron PG 7.5mg/0.75mg/750mcg/75mg/1.5mg Soft Gelatin Capsule may be needed. Please consult your doctor.